Other
Intraoperative
0
Pipeline Programs↗
22
Active Trials↗
1
Companies Involved↗
Intraoperative is an early-stage landscape with 0 programs across 1 company. The most active players are SURGE Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
118
clinical trials
Completed66 · 56%
Unknown status22 · 19%
Recruiting14 · 12%
Terminated6 · 5%
Not yet recruiting6 · 5%
Active, not recruiting2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
118 trials
Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management
Recruiting·—·N/A·NCT06804434·160 enrolled
The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
Recruiting·—·N/A·NCT06015711·96 enrolled
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
Recruiting·—·Phase 1·NCT03107520·125 enrolled
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Recruiting·—·Phase 2·NCT02691923·30 enrolled
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Recruiting·—·Phase 1·NCT06235125·10 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)